Published online Feb 24, 2017. doi: 10.5500/wjt.v7.i1.57
Peer-review started: July 31, 2016
First decision: September 2, 2016
Revised: October 21, 2016
Accepted: January 11, 2017
Article in press: January 13, 2017
Published online: February 24, 2017
Processing time: 207 Days and 10.3 Hours
To present clinical characteristics from renal transplant recipients with dengue fever and its impact on graft function.
We retrospectively evaluated 11 renal transplant recipients (RTR) with dengue infection confirmed by laboratory test, between January 2007 and July 2012, transplanted in the Renal Transplant Center of Walter Cantídio University Hospital from Federal University of Ceará.
Positive dengue serology (IgM) was found in all patients. The mean time between transplant and dengue infection was 43 mo. Fever was presented in all patients. Nine patients presented with classical dengue and two (18%) with dengue hemorrhagic fever. All cases had satisfactory evolution with complete recovery of the symptoms. The time for symptom resolution varied from 2 to 20 d, with an average of 9 d. An increase of creatinine after the infection was observed in three (27.2%) patients with no clinically impact on the kidney graft function.
RTR with dengue infection seems to have a clinical presentation and evolution similar to those seen in the general population, with no long-term damage to patient and to the graft.
Core tip: Dengue is a viral arthropod-borne disease transmitted by mosquitoes of the genus Aedes, mainly Aedes aegypti. The kidney is the most transplanted solid organ in the world with approximately 79000 transplants performed annually. Data are lacking on the clinical presentation of dengue in renal transplant recipients. We retrospectively evaluated 11 renal transplant recipients with dengue infection confirmed by laboratory test, between January 2007 to July 2012, transplanted in the Renal Transplant Center of a tertiary hospital in northeast Brazil.